51˶

Special Reports

Slippery Slope

More in Slippery Slope

Slippery Slope: A Targeted Therapy That Misses the Mark?

Afinitor racks up FDA approvals, but where is the evidence?

Dec 13, 2015
image
Slippery Slope: Does Convenience Trump Safety With NOACs?

Celebrities tout ease of new anticoagulants, but is there real benefit?

Aug 02, 2015
image
Slippery Slope: FDA Reviewer Questions Eliquis Mortality Claim

Trial data from more than 300 patients is missing

Aug 02, 2015
image
Slippery Slope: Diet Drugs No Help for Heart

In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, 51˶ and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.

Apr 19, 2015
image
Slippery Slope: $$ in, Diet Drugs Out, How Five Drugs Came to Market

Makers of diet drugs spent more than $60 million on payments to doctors, organized medicine, and lobbyists to get their drugs approved.

Apr 19, 2015
image
Slippery Slope: Fen-Phen Users Recall a 'Miracle' Turned Nightmare

Fen-phen use was linked to heart valve damage, as these two cases illustrate.

Apr 19, 2015
image